Improvements in the dysfunctional right ventricle with Macitentan treatment in a sugen/hypoxic rat model of pulmonary hypertension
G. Murphy (Glasgow (Glasgow), United Kingdom), G. Jayasekera (Glasgow (Glasgow), United Kingdom), J. Mullin (Glasgow (Glasgow), United Kingdom), L. Gallagher (Glasgow (Glasgow), United Kingdom), Y. Dempsie (Glasgow (Glasgow), United Kingdom), D. Welsh (Glasgow (Glasgow), United Kingdom)
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Session: Experimental approaches to pulmonary hypertension
Session type: E-poster session
Number: 1489
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Murphy (Glasgow (Glasgow), United Kingdom), G. Jayasekera (Glasgow (Glasgow), United Kingdom), J. Mullin (Glasgow (Glasgow), United Kingdom), L. Gallagher (Glasgow (Glasgow), United Kingdom), Y. Dempsie (Glasgow (Glasgow), United Kingdom), D. Welsh (Glasgow (Glasgow), United Kingdom). Improvements in the dysfunctional right ventricle with Macitentan treatment in a sugen/hypoxic rat model of pulmonary hypertension. 1489
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: